Established in 2001, the Verheilen GMBH headquarters was built at the heart of Kaiserslautern in Southwest Germany. At this time, we introduced our first pharmaceutical products,Incid (Ranitidine), followed by Cardioten(Atenolol), both later exported to Asia.In 2003,Verheilen found an additional home in the Philippines. Our portfolio initially focused on cardiovascular and anti-infective therapies, eventually foraying into the antihistamine market with the launching of Zinex (Cetirizine). Within three years, this Asian expansion effort was at full throttle with Verheilen sealing a strategic partnership with India which included the transfer of technology and expertise.During the same year of 2006, Verheilen entered the Spanish market via SugarwoodFarma SL. Assigned as the sole importer and distributor of SugarWoods SL products in the Philippines was Farmalberica Incorporated (Phil). In 2014,the Iberica –VerheilemPharma Group was formed in the Philippines as the marketing arm of both Verheilen GMBH and SugarWood SL now Farmalberica-Catalan SL.Over more than a decade, the Verheilen Pharma Group has grown its product portfolio with the inclusion of various therapeutic areas, such as anti –diabetics pain management ,anti-psychosis, anti- cholesterol drugs, and injectibles, as well as nasal sprays, inhalers , and insulin lines in the future.
Established in 2001, the Verheilen GMBH headquarters was built at the heart of Kaiserslautern in Southwest Germany. At this time, we introduced our first pharmaceutical products,Incid (Ranitidine), followed by Cardioten(Atenolol), both later exported to Asia.In 2003,Verheilen found an additional home in the Philippines. Our portfolio initially focused on cardiovascular and anti-infective therapies, eventually foraying into the antihistamine market with the launching of Zinex (Cetirizine). Within three years, this Asian expansion effort was at full throttle with Verheilen sealing a strategic partnership with India which included the transfer of technology and expertise.During the same year of 2006, Verheilen entered the Spanish market via SugarwoodFarma SL. Assigned as the sole importer and distributor of SugarWoods SL products in the Philippines was Farmalberica Incorporated (Phil). In 2014,the Iberica –VerheilemPharma Group was formed in the Philippines as the marketing arm of both Verheilen GMBH and SugarWood SL now Farmalberica-Catalan SL.Over more than a decade, the Verheilen Pharma Group has grown its product portfolio with the inclusion of various therapeutic areas, such as anti –diabetics pain management ,anti-psychosis, anti- cholesterol drugs, and injectibles, as well as nasal sprays, inhalers , and insulin lines in the future.
Established in 2001, the Verheilen GMBH headquarters was built at the heart of Kaiserslautern in Southwest Germany. At this time, we introduced our first pharmaceutical products,Incid (Ranitidine), followed by Cardioten(Atenolol), both later exported to Asia.In 2003,Verheilen found an additional home in the Philippines. Our portfolio initially focused on cardiovascular and anti-infective therapies, eventually foraying into the antihistamine market with the launching of Zinex (Cetirizine). Within three years, this Asian expansion effort was at full throttle with Verheilen sealing a strategic partnership with India which included the transfer of technology and expertise.During the same year of 2006, Verheilen entered the Spanish market via SugarwoodFarma SL. Assigned as the sole importer and distributor of SugarWoods SL products in the Philippines was Farmalberica Incorporated (Phil). In 2014,the Iberica –VerheilemPharma Group was formed in the Philippines as the marketing arm of both Verheilen GMBH and SugarWood SL now Farmalberica-Catalan SL.Over more than a decade, the Verheilen Pharma Group has grown its product portfolio with the inclusion of various therapeutic areas, such as anti –diabetics pain management ,anti-psychosis, anti- cholesterol drugs, and injectibles, as well as nasal sprays, inhalers , and insulin lines in the future.